Roche completes buildings as part of $300M overhaul
Since 2012, the company has built five buildings, refurbished existing buildings, made upgrades to IT infrastructure, and increased investments in its diabetes care manufacturing technology.
Health Care & Life Sciences
Articles
Drug firms fighting ‘tooth and nail’ against California ballot measure
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
Lilly sales, profit disappoint in final earnings report under Lechleiter
Sales of Lilly's Humalog insulin, its top-selling product, fell 9 percent, to $641 million, offsetting gains by a stable of new drugs that is helping the company weather a blitz of patent expirations.
Obama administration confirms double-digit premium hikes
Obamacare premiums will go up sharply next year under and many consumers will be down to just one insurer to choose from, the administration confirmed Monday.
IU’s new data science degree taps into hot health care market
The new degree blends such disciplines as biostatistics, computer science and informatics to better understand issues related to health care cost and quality.
Community Hospital North reopens 6 operating rooms
The hospital voluntarily closed the rooms Oct. 10 after finding discoloration on ceiling tiles and walls in a nearby corridor area.
Rules mandate some firms cover transgender services
Starting Jan. 1, any health care organization that takes federal money for health purposes can’t refuse to provide transgender services.
Lilly cancer drug lands accelerated FDA approval
Lartruvo is the first front-line therapy approved by the FDA to treat soft tissue sarcomas since doxorubicin more than 40 years ago.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Purdue startup focuses on prostate cancer therapy
Research developed at Purdue University and licensed by a biomedical startup could give patients with late-stage prostate cancer an alternative to hormone therapies that can develop resistance after prolonged use.
Obama administration sets 13.8M goal for ACA sign-up season
This is shaping up to be the most difficult sign-up season since HealthCare.gov launched in 2013. Premiums are going up sharply in many parts of the country, and some major insurers have exited the program, leaving consumers with fewer choices.
Lilly pledges $90 million to improve global drug access
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
Mainstreet accused of not paying nearly $2M in fees to adviser
A Chicago investment broker says the Carmel-based developer of transitional care properties is refusing to pay up for lining up a major investor in several projects.
Princeton to pay $18 million to settle residents’ tax case
The residents who sued sought to revoke the school’s property-tax exemption, in part because Princeton shares commercial royalties with faculty from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.
Medicare unveils far-reaching overhaul of doctors’ pay
The majority of medical professionals billing Medicare—some 600,000 doctors, nurse practitioners, physician assistants and therapists—will be affected.
Obamacare enrollment predicted to see ‘significant slowdown’ next year
Enrollment in the Obamacare insurance marketplace is likely to stall or even decline for 2017 after two years of growth, according to S&P Global Ratings forecasts.
Feds snag Mainscape owner in American Senior Communities probe
The U.S. Attorney’s Office in Indianapolis filed a felony count against Mainscape CEO Dave Mazanowski on Wednesday alleging he was a willing participant in a fraud and kickback scheme orchestrated by former American Senior Communities CEO James Burkhart.
UPDATED: Feds say ASC’s CEO, 3 others used kickbacks, shell firms to pull off massive fraud
An indictment unsealed Wednesday alleges former American Senior Communities CEO James Burkhart orchestrated a massive scheme that defrauded the nursing home company, its owner and federal health care programs out of more than $16 million.
Community Hospital North shuts down 6 operating rooms
The hospital said Monday afternoon it had decided to voluntarily suspend the use of the operating rooms while it conducts air-quality tests.
Mandatory flu vaccines remain a sticking point in Indiana
The issue has continued to flare up regularly since Indiana University Health fired eight employees in 2012 for refusing to get a flu vaccination.